DGX - Quest Diagnostics - Stock Price & Dividends

Quest Diagnostics Incorporated is a leading provider of diagnostic testing and services, operating in the United States and internationally. The company's comprehensive portfolio includes routine, non-routine, and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

Through its extensive network of laboratories, patient service centers, and healthcare professionals, Quest Diagnostics delivers diagnostic information services to a diverse range of clients, including physicians, hospitals, patients, consumers, health plans, government agencies, employers, retailers, pharmaceutical companies, insurers, and accountable care organizations. The company's services are offered under various brands, including Quest Diagnostics, AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

In addition to its diagnostic testing services, Quest Diagnostics also provides risk assessment services for the life insurance industry. Furthermore, the company offers healthcare organizations and clinicians information technology solutions to support their operations and decision-making processes.

Founded in 1967, Quest Diagnostics Incorporated is headquartered in Secaucus, New Jersey, and has established itself as a trusted partner in the healthcare industry, committed to providing high-quality diagnostic information services that enable better patient care and outcomes. You can learn more about the company's services and initiatives on its website at https://www.questdiagnostics.com.